Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into phase 2. The Waltham, Massachusetts-based company already unveiled ...

Objective: Oral submucous fibrosis (OSF) is a chronic oral mucosal disease, which exerts a profound impact on patients’ daily life and currently lacks efficacious therapeutic interventions.

to provide a comprehensive overview of oral cavity cancer including its symptoms, causes, prevention and treatment. Here is everything he shared with us. According to the Mayo Clinic, oral cavity ...

Department of Oral Anatomy and Physiology, Jilin Provincial Key Laboratory of Oral Biomedical Engineering, Hospital of Stomatology, Jilin University, Changchun, China Oral squamous cell carcinoma ...

As soon as I saw the house, I knew it was for us. You just feel that essence of 'this is a home with a hug.'" Cystic fibrosis causes sticky mucus to build up in the lungs and digestive system. This ...